Suppr超能文献

口服普罗帕酮与静脉注射胺碘酮用于近期发作房颤转复的疗效及转复速度:一项随机对照比较研究。

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study.

作者信息

Taha Hesham S, Youssef Ghada, Omar Ramy M, Kamal El Din Ahmed M, Shams El Din Ahmed A, Meshaal Marwa S

机构信息

Cardiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

National Heart Institute, Cairo, Egypt.

出版信息

Indian Heart J. 2022 May-Jun;74(3):212-217. doi: 10.1016/j.ihj.2022.04.006. Epub 2022 Apr 19.

Abstract

BACKGROUND

Atrial fibrillation is the most commonly encountered arrhythmia. Several antiarrhythmic agents are effective in restoring and maintaining sinus rhythm.

AIM OF THE WORK

To compare the efficacy and rapidity of conversion of recent onset atrial fibrillation using oral propafenone versus intravenous infusion of amiodarone.

METHODS

The study included 200 patients with recent onset atrial fibrillation. Patients were equally divided into 2 groups; group A where intravenous infusion amiodarone was given and group B where oral propafenone was administrated. The effectiveness and the time needed for conversion of atrial fibrillation to sinus rhythm were compared in both groups.

RESULTS

The success of conversion of atrial fibrillation to sinus rhythm was 83% in group A and 85% in group B, p-value = 0.699. The time elapsed from drug administration till conversion of atrial fibrillation was 9.07 ± 5.04 hours in group A versus 3.9 ± 1.54 hours in group B, p-value = 0.001. In both groups, patients who showed failed conversion had a significantly larger left atrial diameter and a significantly higher high sensitivity C-reactive protein (hsCRP) level.

CONCLUSION

Oral propafenone was faster than parenteral amiodarone in the conversion of recent onset atrial fibrillation to sinus rhythm. Patients with failed conversion had a bigger left atrial diameter and a higher hsCRP when compared to patients with successful conversion.

摘要

背景

心房颤动是最常见的心律失常。几种抗心律失常药物在恢复和维持窦性心律方面有效。

研究目的

比较口服普罗帕酮与静脉输注胺碘酮转复近期发作心房颤动的疗效和速度。

方法

该研究纳入200例近期发作心房颤动患者。患者平均分为两组;A组给予静脉输注胺碘酮,B组给予口服普罗帕酮。比较两组心房颤动转复为窦性心律的有效性及所需时间。

结果

A组心房颤动转复为窦性心律的成功率为83%,B组为85%,p值 = 0.699。从给药到心房颤动转复的时间,A组为9.07 ± 5.04小时,B组为3.9 ± 1.54小时,p值 = 0.001。两组中,转复失败的患者左心房直径显著更大,高敏C反应蛋白(hsCRP)水平显著更高。

结论

在近期发作心房颤动转复为窦性心律方面,口服普罗帕酮比胃肠外给予胺碘酮更快。与转复成功的患者相比,转复失败的患者左心房直径更大,hsCRP更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79a/9243606/1001d0fc3cde/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验